Alzoubi Fawaz, Bedrossian Edmond, Wong Allen, Farrell Douglas, Park Chan, Indresano Thomas
Int J Oral Maxillofac Implants. 2017 Jul/Aug;32(4):897-903. doi: 10.11607/jomi.5519.
To assess outcomes of treating completely edentulous patients with a fixed implant-supported profile prosthesis utilizing a graftless approach for the maxilla and for the mandible, with emphasis on clinically related outcomes, specifically implant and prosthesis survival.
This was a retrospective study with the following inclusion criteria: completely edentulous patients rehabilitated with a fixed implant-supported profile denture utilizing a graftless approach. Patients fulfilling the inclusion criteria were asked to participate in the study during their follow-up visits, and hence a consecutive sampling strategy was used. Data regarding implant and prosthesis cumulative survival rates (CSRs) were gathered and calculated.
Thirty-four patients were identified with a total of 220 implants placed. An overall CSR of 98.2% was recorded with an observation of up to 10 years. For tilted, axial, and zygomatic implants, CSRs of 96.9%, 98.0%, and 100%, respectively, were observed for up to 10 years. For provisional prostheses, CSRs of 92.3% at 1 year, and 84.6% at 2 years were observed. For final prostheses, a CSR of 93.8% was observed at 10 years.
The results suggest that treating completely edentulous patients with a fixed profile prosthesis utilizing a graftless approach in the maxilla and the mandible can be a reliable treatment option.
评估采用无植骨方法对上颌骨和下颌骨完全无牙患者进行固定种植体支持的轮廓修复体治疗的效果,重点关注临床相关结果,特别是种植体和修复体的存活率。
这是一项回顾性研究,纳入标准如下:采用无植骨方法通过固定种植体支持的轮廓义齿修复的完全无牙患者。符合纳入标准的患者在随访期间被邀请参与研究,因此采用了连续抽样策略。收集并计算了关于种植体和修复体累积存活率(CSR)的数据。
共确定了34例患者,共植入220颗种植体。观察长达10年,总体CSR为98.2%。对于倾斜种植体、轴向种植体和颧骨种植体,观察长达10年的CSR分别为96.9%、98.0%和100%。对于临时修复体,1年时的CSR为92.3%,2年时为84.6%。对于最终修复体,10年时的CSR为93.8%。
结果表明,对上颌骨和下颌骨完全无牙患者采用无植骨方法进行固定轮廓修复体治疗可能是一种可靠的治疗选择。